Natural Killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II)
about
Natural killer cells and autoimmunityRe-evaluating the role of natural killer cells in innate resistance to herpes simplex virus type 1Genetic Causes of Human NK Cell Deficiency and Their Effect on NK Cell SubsetsNatural killer cells in infection and inflammation of the lungDeficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations.Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus.HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATR-mediated DNA damage responseClinical correlates of herpes simplex virus viremia among hospitalized adultsImmunobiology of herpes simplex virus and cytomegalovirus infections of the fetus and newbornNatural killer cell function and dysfunction in hepatitis C virus infection.Ig-binding receptors on human NK cells as effector and regulatory surface molecules.Arrested natural killer cell development associated with transgene insertion into the Atf2 locusSevere viral infections and primary immunodeficiencies.Deciphering the Multifaceted Relationship between Oncolytic Viruses and Natural Killer CellsUnraveling human natural killer cell deficiencyVaricella-Zoster Virus and Herpes Simplex Virus 1 Differentially Modulate NKG2D Ligand Expression during Productive Infection.Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicityThe immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention.Natural killer cell functional defects in pediatric patients with severe and recurrent herpesvirus infectionsA novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease.A patient-specific therapeutic approach for tumour cell population extinction and drug toxicity reduction using control systems-based dose-profile design.Biallelic mutations in IRF8 impair human NK cell maturation and functionNatural killer cell deficiency.Low-affinity Fcgamma receptors, autoimmunity and infection.Natural killer cells in human autoimmune disordersNatural killer cells in inflammatory heart disease.Practical NK cell phenotyping and variability in healthy adults.Eight-color immunophenotyping of T-, B-, and NK-cell subpopulations for characterization of chronic immunodeficiencies.Beta and Gamma Human Herpesviruses: Agonistic and Antagonistic Interactions with the Host Immune System.Frequency analysis of the g.7081T>G/A and g.10872T>G polymorphisms in the FCGR3A gene (CD16A) using nested PCR and their functional specific effects.Molecular Basis for the Recognition of Herpes Simplex Virus Type 1 Infection by Human Natural Killer Cells.Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients.Natural killer cell deficiencies in a consecutive series of children with herpetic encephalitis.Natural killer cells as a therapeutic tool for infectious diseases - current status and future perspectives.NKG2D: A Master Regulator of Immune Cell Responsiveness.
P2860
Q24793284-7756AAB0-E121-4389-9F96-AF4FA9DA2F42Q24814677-F5272B44-B2BA-4A12-B1F3-E9604C20FB62Q28067993-10F8ACDA-3FB6-45A6-86F2-BBAEC4D9134DQ28391714-657BC919-B28C-4E8D-930D-45EE05D10A49Q30453097-3FA1F890-5568-41E0-9846-87DC3867B211Q33384708-794C2EF1-93AC-4B74-87C9-8A964F141271Q33508241-597BB8EB-F210-4984-87EA-DC37552406D4Q33577281-1057CC2C-4024-42ED-AC67-8D4DBCB37DB7Q33835386-F1F8EC1A-8F34-4908-9B4D-924F886826F9Q33892695-BDD1A1EE-8070-4659-97A0-4A9AC1962584Q34552149-361E22D8-231A-4022-9018-34C81E7E198FQ34595021-F7C01CE0-CF45-4128-989F-2E512571BA92Q35290347-F6AB80BA-F5E5-4598-8516-A70FF81827D1Q35687743-79B0FC37-FF60-4A3B-96C1-20101DBB563AQ35780328-44B14C18-A3D4-4F6E-B917-E430E5A505B8Q35861220-F672C457-D537-4F1E-923B-725945CE20DBQ36290349-5AC16C7A-140D-4623-B2ED-93C94D29E7B2Q36765590-4D052A24-C346-4A43-B2BB-2CE65ED9E47EQ36957244-00F17AF9-A0AD-4A60-B3B5-6AC570531F15Q37371654-DEE7FD3C-02D5-4FEF-A3BA-BB8617A2DD5FQ37497227-F20DA4F3-A552-4C49-B73A-0827DCC62316Q37545040-85995B4D-60C5-446D-8689-83D3D780C106Q37567421-207F52C6-E236-4FE9-9A93-6E68578C1492Q37578785-F5A3BCD2-E11E-4634-990F-0BF2A091F02AQ37690952-6D8BFE3B-D97D-46C4-95CB-3E21B22B4A7CQ39022829-873EFABF-7B08-48F3-94A8-E53B084E39C6Q41976950-B58727D4-C426-4740-8BFF-E06920A484ABQ46129819-24253E35-A114-4DBF-869F-E53A96940739Q47550811-C0B7B7E4-7C78-44EA-912A-C8B50E7D3902Q48548930-9F840AE8-2593-42E3-9F5F-2FFC182CA5ECQ50282161-3F1BF8F1-EA2A-4A09-97E2-014D044C9B47Q50764796-734E1017-5015-47BB-AA17-5EB74D367C35Q50788420-9232353B-CA58-4686-BDD7-26EF2D8A6990Q54213151-6431D6BE-75C8-4446-BB1A-9B160D6EEC9CQ55216305-9E2129C0-978D-4A64-87A5-3E02A5C5973D
P2860
Natural Killer (NK) cell deficiency associated with an epitope-deficient Fc receptor type IIIA (CD16-II)
description
im März 1996 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 March 1996
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 1996
@uk
name
Natural Killer (NK) cell defic ...... c receptor type IIIA (CD16-II)
@en
Natural Killer
@nl
type
label
Natural Killer (NK) cell defic ...... c receptor type IIIA (CD16-II)
@en
Natural Killer
@nl
prefLabel
Natural Killer (NK) cell defic ...... c receptor type IIIA (CD16-II)
@en
Natural Killer
@nl
P2093
P2860
P1476
Natural Killer (NK) cell defic ...... c receptor type IIIA (CD16-II)
@en
P2093
P2860
P304
P356
10.1111/J.1365-2249.1996.TB08295.X
P407
P577
1996-03-01T00:00:00Z